The outbreak of novel coronavirus 2019-nCoV ("Coronavirus") is an extraordinary challenge for many transactions involving Chinese companies. In this section, we analyse its impact on certain key aspects of mergers and...more
2/18/2020
/ Best Practices ,
China ,
Coronavirus/COVID-19 ,
Corporate Sales Transactions ,
Covered Transactions ,
Financial Markets ,
Force Majeure Clause ,
Infectious Diseases ,
Investment ,
Investor Protection ,
Investors ,
Joint Venture ,
Market Conditions ,
Material Adverse Effects ,
Public Health ,
Risk Management ,
Share Purchase Agreements
Ever since China began opening up to the outside world, the right of foreign-invested enterprises ("FIEs") to make equity investments within the People's Republic of China (which for these purposes refers to Mainland China...more
12/2/2019
/ Capital Contributions ,
China ,
Cross-Border Transactions ,
Equity Investors ,
Financial Institutions ,
Financial Regulatory Reform ,
Foreign Investment ,
Foreign Investment Entities (FIEs) ,
Free Trade Zone ,
Investment ,
Investment Opportunities ,
Regulatory Standards ,
State Administration of Foreign Exchange (SAFE)
Announced in 2013 as the project of the century, Chinese President Xi Jinping unveiled the Belt and Road Initiative ("BRI") to revitalise trade and economic growth in the Eurasian region....more
On 30 June 2016, the industry self-regulating body, the Asset Management Association of China published what, on the face of it, appeared to be a fairly innocuous document entitled Questions and Answers regarding the...more